 In 1992 ALK and Abello merged.In the 1990s, ALK was the first company to launch sublingual immunotherapy drops (allergy immunotherapy administered as droplets under the tongue).In recent years, ALK’s research and development strategy has been focused on introducing a range of sublingual immunotherapy tablets (SLIT-tablets).